Burning Rock Biotech (BNR) Treasury Shares (2020 - 2026)

Burning Rock Biotech's Treasury Shares history runs 6 years deep, the most recent figure standing at $726.6 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 8542.57% year-over-year to $726.6 million; the TTM figure through Mar 2026 stood at $726.6 million (up 8542.57% YoY), while the FY2025 annual figure was $8.2 million, down 5.64% from the prior year.
• Treasury Shares for Q1 2026 stood at $726.6 million, up from -$8.1 million in the prior quarter.
• The five-year high for Treasury Shares was $426240.1 in Q4 2025, with the low at $35292.7 in Q4 2022.
• The 5-year median for Treasury Shares is $419875.8 (2023), against an average of $279657.9.
• The sharpest annual moves came in 2023 and 2026: Treasury Shares slumped 1569.07% in 2023, then soared 8542.57% in 2026.
• Burning Rock Biotech's Treasury Shares stood at $8.3 million in 2022, then grew by 10.48% to $9.2 million in 2023, then decreased by 3.77% to $8.8 million in 2024, then plunged by 191.56% to -$8.1 million in 2025, then surged by 9110.25% to $726.6 million in 2026.
• Business Quant data shows BNR's Treasury Shares at $726.6 million in Q1 2026, -$8.1 million in Q4 2025, and -$8.0 million in Q3 2025.